News Releases
Nestlé Issues Lean Cuisine Recall Due to Undeclared Shrimp
Nestlé Prepared Foods Company, a business unit of Nestlé USA, is initiating the voluntary recall of a limited quantity of LEAN CUISINE® Culinary Collection Chicken with Peanut Sauce/UPC code 13800 10154 because it may contain undeclared shrimp.
Undeclared Eggs Lead to Allergy Alert on Snack
Seoul Shik Poom Inc. of Englewood, NJ is recalling Choripdong Chocolate Almond Richmond Ice Bar (4bags/432ml) because they may contain undeclared eggs.
Undeclared Milk in LifeCore Chocolate Products
Ortho Molecular Products of Stevens Point, Wisconsin is recalling all lots of LifeCore Chocolate and LifeCore Complete Chocolate because the flavoring may contain undeclared milk.
Undeclared Milk in Uprising Brand Drinks
New York State Agriculture Commissioner Richard A. Ball today alerted consumers to undeclared milk in Uprising Brand “Carrot Drink,” “Beet Drink,” and “Peanut Punch,” distributed by Erlo Distribution Inc., Brooklyn, NY.
Health Canada Endorsed Important Safety Information on Sutent (sunitinib malate) Capsules
Pfizer Canada Inc. (manufacturer of Sutent), in collaboration with Health Canada, would like to inform you about an important revision to the Product Monograph, including the consumer information section, for Sutent (sunitinib malate).
New Drug Application for Amitiza Approved
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals USA, Inc. announced today that the FDA has approved Sucampo’s supplemental new drug application (sNDA) for AMITIZA ® (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Pfizer And Astrazeneca Combine for OTC Nexium
Pfizer Inc. announced that it has entered into an agreement with AstraZeneca for the over-the-counter (OTC) rights for NEXIUM (esomeprazole magnesium), a leading prescription drug currently approved to treat the symptoms of gastroesophageal reflux disease (GERD).
Abbott Drug Gets Positive Review in Ulcerative Colitis
Abbott announced that the European Committee for Medicinal Products for Human Use ( CHMP ) has issued a positive opinion for Humira ( adalimumab ) in adults with moderate to severely active ulcerative colitis ( UC ) who have not responded to, cannot tolerate or have medical contraindications to conventional therapies.